Contraception
Volume 79, Issue 5 , Pages 385-392 , May 2009

First-trimester surgical abortion practices: a survey of National Abortion Federation members

  • Katharine O'Connell

      Affiliations

    • Department of Obstetrics and Gynecology, Columbia University, New York, NY 10032, USA
    • Corresponding Author InformationCorresponding author.
    • ,
  • Heidi E. Jones

      Affiliations

    • Department of Obstetrics and Gynecology, Columbia University, New York, NY 10032, USA
    • ,
  • Melissa Simon

      Affiliations

    • Department of Obstetrics and Gynecology, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA
    • ,
  • Vicki Saporta

      Affiliations

    • National Abortion Federation, Washington, DC 20036, USA
    • ,
  • Maureen Paul

      Affiliations

    • Department of Obstetrics and Gynecology, Mount Sinai School of Medicine, New York, NY 10029, USA
    • ,
  • E. Steve Lichtenberg

      Affiliations

    • Department of Obstetrics and Gynecology, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA

Received 24 June 2008 ,Revised 7 November 2008 ,Accepted 10 November 2008.

References 

  1. Jones RK, Zolna MRS, Henshaw SK, Finer LB. Abortion in the United States: incidence and access to services, 2005. Perspect Sexual Reprod Health. 2008;40:6–16
  2. Strauss LT, Gamble SB, Parker WY, Cook DA, Zane SB, Hamden S. Abortion surveillance — United States, 2004. MMWR Surveill Summ. 2007;56:1–33
  3. Landy U, Lewit S. Administrative, counseling and medial practices in National Abortion Federation facilities. Fam Plann Perspect. 1982;14:257–262
  4. Lichtenberg ES, Paul M, Jones H. First trimester surgical abortion practices: a survey of National Abortion Federation members. Contraception. 2001;64:345–352
  5. National Abortion Federation . Clinical policy guidelines. Washington, DC: National Abortion Federation; 2002;
  6. O'Connell K, Jones H, Lichtenberg ES, Paul M. Second trimester surgical abortion practices: a survey of National Abortion Federation members. Contraception. 2008;78(6):492–499
  7. Finer LB, Henshaw SK. Estimates of US abortion incidence, 2001–2003. Perspect Sexual Reprod Health. 2003;35:6–15
  8. Strauss LT, Herndon J, Chang J, et al. CDC. Abortion surveillance — United States, 2001. MMWR Surveill Summ. 2004;53:1–32
  9. Statistics Canada, Health Statistics Division . Induced abortions by province and territory of report. CANSIM, table 106-9005 and catalogue no. 82-223-X. Ottawa (Ontario, Canada): Canadian Institute for Health Information; 2001;http://www40.statcan.ca/l01/cst01/health40a.htm
  10. Grimes DA. Clinicians who provide abortions: the thinning ranks. Obstet Gynecol. 1992;80:719–723
  11. Eastwood KL, Kacmar JE, Steinhauer J, Weitzen S, Boardman LA. Abortion training in United States obstetrics and gynecology residency programs. Obstet Gynecol. 2006;108:303–308
  12. Grimes DA, Schulz KF, Cates W. Prevention of uterine perforation during curettage abortion. JAMA. 1984;251:2108–2111
  13. Lindell G, Flam F. Management of uterine perforations in connection with legal abortions. Acta Obstet Gynecol Scand. 1995;74:373–375
  14. Hale RW, Reich LA, Joiner JM, Pion RJ, Kobara T. Histopathologic evaluation of uteri curetted by flexible suction cannula. Am J Obstet Gynecol. 1976;125:805–808
  15. Henry J. Kaiser Family FoundationThe Picker Institute. From the patient's perspective: quality of abortion care. Menlo Park (Calif): Kaiser Family Foundation and The Picker Institute; 1999;
  16. Bartlett LA, Berg CJ, Shulman HB, et al. Risk factors for legal induced abortion-related mortality in the United States. Obstet Gynecol. 2004;103:729–737
  17. Goldberg AB, Dean G, Kang MS, Youssof S, Darney PD. Manual versus electric vacuum aspiration for early first-trimester abortion: a controlled study of complication rates. Obstet Gynecol. 2004;103:101–107
  18. Paul M, Mitchell C, Rogers A, Fox M, Lackie E. Early surgical abortion: efficacy and safety. AJOG. 2002;187:407–411
  19. Creinin MD, Edwards J. Early abortion: surgical and medical options. Curr Probl Obstet Gynecol Fertil. 1997;20:11–19
  20. Paul M, Lichtenberg ES, Borgatta L, Grimes DA, Stubblefield PG. A clinician's guide to medical and surgical abortion. New York: Churchill Livingstone; 1999;
  21. Darney PD, Atkinson E, Hirabayashi K. Uterine perforation during second-trimester abortion by cervical dilation and instrumental extraction: a review of 15 cases. Obstet Gynecol. 1990;75:441–444
  22. de Jonge ET, Jewkes R, Levin J, Rees H. Randomised controlled trial of the efficacy of misoprostol used as a cervical ripening agent prior to termination of pregnancy in the first trimester. S Afr Med J. 2000;90:256–262
  23. Ngai SW, Yeung KC, Lao T, Ho PC. Oral misoprostol versus vaginal gemeprost for cervical dilatation prior to vacuum aspiration in women in the sixth to twelfth week of gestation. Contraception. 1995;51:347–350
  24. Hakim-Elahi E, Tovell HM, Burnhill MS. Complications of first-trimester abortion: a report of 170,000 cases. Obstet Gynecol. 1990;76:129–135
  25. Allen RH, Goldberg AB Board of Society of Family Planning. Cervical dilation before first-trimester surgical abortion (<14 weeks' gestation). SFP guideline 2007. Contraception. 2007;76:139–156
  26. Renton A, Thomas BM, Gill S, Lowndes C, Taylor-Robinson D, Patterson K. Chlamydia trachomatis in cervical and vaginal swabs and urine specimens from women undergoing termination of pregnancy. Int J STD AIDS. 2006;17:443–447
  27. Rose S, Lawton B, Brown S, Goodyear-Smith F, Arroll B. High rates of chlamydia in patients referred for termination of pregnancy: treatment, contact tracing, and implications for screening. N Z Med J. 2005;118:U1348
  28. Mallinson H, Hopwood J, Skidmore S, Fenton K, Phillips C, Jones I. Provision of chlamydia testing in a nationwide service offering termination of pregnancy: with data capture to monitor prevalence of infection. Sex Transm Infect. 2002;78:416–421
  29. Chen S, Li J, van den Hoek A. Universal screening or prophylactic treatment for Chlamydia trachomatis infection among women seeking induced abortions: which strategy is more cost-effective?. Sex Transm Dis. 2007;34:230–236
  30. Groom TM, Stewart P, Kruger H, Bell G. The value of a screen and treat policy for Chlamydia trachomatis in women attending for termination of pregnancy. J Fam Plann Reprod Health Care. 2001;27:69–72
  31. Cameron ST, Sutherland S. Universal prophylaxis compared with screen-and-treat for Chlamydia trachomatis prior to termination of pregnancy. BJOG. 2002;109:606–609
  32. Sawaya GF, Grady D, Kerlikowske K, Grimes DA. Antibiotics at the time of induced abortion: the case for universal prophylaxis based on a meta-analysis. Obstet Gynecol. 1996;87:884–890
  33. Paul M, Lackie E, Mitchell C, Rogers A, Fox M. Is pathology examination useful after early surgical abortion?. Obstet Gynecol. 2002;99:567–571

☆ Financial support was provided by an anonymous foundation.

☆☆ Melissa Simon is the recipient of a National Institutes of Health K-12 award (HD050121-02). Work for this study and manuscript development were performed outside of her commitment to this funding award.

PII: S0010-7824(08)00520-9

doi: 10.1016/j.contraception.2008.11.005

Contraception
Volume 79, Issue 5 , Pages 385-392 , May 2009

Article Tools

* Image Usage & Resolution